Atlas Trials

Mesothelioma, Malignant

31 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Mesothelioma, Malignant

RecordFirmDate
Niraparib Efficacy in Patient With Unresectable Mesothelioma (NCT05455424)University Hospital Southampton NHS Foundation Trust2022-07-11
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849)TCR2 Therapeutics2022-06-21
......SMARTEST Trial...... (NCT05380713)University Health Network, Toronto2022-05-03
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma (NCT04823741)Hospices Civils de Lyon2022-02-11
A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants (NCT05136677)Bristol-Myers Squibb2022-01-25
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) (NCT05324436)Bristol-Myers Squibb2022-01-08
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119)A2 Biotherapeutics Inc.2021-10-29
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma (NCT04214015)ProgenaBiome2020-03-02
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (NCT03546426)Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2019-12-12
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas (NCT04104776)Novartis Pharmaceuticals2019-09-18
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469)ProgenaBiome2019-07-11
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer (NCT03907852)TCR2 Therapeutics2019-04-15
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma (NCT03502746)Arkadiusz Z. Dudek, MD2018-06-26
Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma (NCT03393858)Capital Medical University2017-12-01
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) (NCT02357147)Morphotek2015-11-03
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma (NCT02303899)Istituto Clinico Humanitas2014-11-01
Malignant Mesothelioma - Can we Improve Quality of Life (NCT03068117)Portsmouth Hospitals NHS Trust2014-04-03

Track Mesothelioma, Malignant automatically

Every clearance here is in the API, with alerts when new ones post.